Ketamine Contraindications Explained: A Clear Guide

What ketamine contraindications mean

Ketamine contraindications are medical situations in which ketamine should not be used, or should be postponed until a clinician can assess and reduce a specific risk. They are not a universal checklist: the relevant contraindications differ between generic ketamine, which is commonly prescribed off-label for depression, and FDA-approved esketamine nasal spray, sold as Spravato.

A clinician usually considers your cardiovascular history, pregnancy status, current medicines, substance-use history, psychiatric symptoms, and the setting in which treatment would occur. This article explains screening language for education, not medical advice. A licensed clinician who knows your history can advise whether a treatment is appropriate for you.

Absolute contraindication, precaution, and screening factor are different terms

An absolute contraindication means the product label says the medicine should not be used in a defined situation. A precaution, sometimes called a warning, means use may still be possible but requires clinician judgment and safeguards. A screening factor is broader: it is any part of your history that helps a prescriber decide whether potential benefit and risk are balanced.

• Contraindication: a labeled reason not to use a medicine.
• Precaution: a concern that can require monitoring, dose changes, consultation, or delaying treatment.
• Risk-benefit assessment: a clinician's individualized comparison of possible benefits, harms, and alternatives.
• Medical clearance: an evaluation, sometimes from another clinician, to clarify whether a health condition is stable enough for a proposed treatment.

Ketamine is a dissociative anesthetic definition and drug class examples resource can help explain. Dissociation can be expected at some doses, but its intensity and clinical meaning differ across settings. See ketamine dissociation meaning for the term's plain-language definition.

Health conditions that may change a ketamine plan

Some conditions are not always a blanket reason to rule out ketamine, but they can change whether, where, and how it is considered. The facts that matter include the condition's severity, whether it is stable, your current treatment, the planned route, and the monitoring available.

Cardiovascular and blood-pressure history

Because ketamine can increase blood pressure and heart rate, clinicians commonly ask about uncontrolled hypertension, chest pain, prior stroke, aneurysm, heart rhythm concerns, and other cardiovascular disease. The FDA ketamine hydrochloride injection label states that ketamine is contraindicated when a blood-pressure elevation would create a serious hazard. That wording does not mean every person with hypertension has the same risk, which is why assessment matters.

Psychiatric and substance-use history

Screening may include current psychosis, mania or hypomania, severe dissociation, and past or current substance-use disorder. These questions do not assign blame or automatically determine eligibility. They help a clinician plan for symptom worsening, misuse risk, follow-up, and safety. An intense recovery-period experience can be described as an ketamine emergence reaction definition, which is distinct from every form of dissociation.

Medication, pregnancy, and bladder questions belong in screening

Your medication list and reproductive health information can affect the safety discussion even when they do not appear on a short contraindication list. Bring prescriptions, over-the-counter medicines, supplements, alcohol use, and other substance use to a clinician's attention. Sedatives and alcohol can add to sedation or breathing risk, while certain medicines may affect blood pressure or mental-state monitoring.

The FDA labeling for ketamine and Spravato contains specific warnings and drug-interaction information that a prescriber should review in context. If you are pregnant, planning pregnancy, or breastfeeding, discuss this before treatment. The Spravato label advises that treatment is not recommended during pregnancy because of potential embryo-fetal risk described in animal data.

Long-term, frequent nonmedical ketamine exposure has been associated with urinary tract problems. The evidence and its limits are explained in ketamine-induced cystitis bladder toxicity research. New urinary pain, urgency, or blood in urine deserves prompt clinical attention, regardless of the cause.

Why route and supervision matter after screening

A favorable screening discussion does not make every ketamine route interchangeable. Intravenous, intramuscular, sublingual, intranasal, and oral approaches differ in onset, absorption, dose control, and supervision. Bioavailability understanding ketamine absorption by route explains why the same milligram amount can have different effects by route.

Spravato is an esketamine nasal spray with an FDA Risk Evaluation and Mitigation Strategy, or REMS, program. According to the FDA-approved Spravato prescribing information, patients must be monitored for at least two hours after administration because of risks including sedation, dissociation, and respiratory depression. Generic ketamine does not have FDA approval for depression, though clinicians may prescribe an approved drug off-label when they judge it appropriate.

Research can clarify possible benefits and harms, but a study result is not an eligibility decision. Use how to read ketamine depression research studies to assess whether a study's participants, route, and follow-up resemble the question you are trying to answer.

How to use this information safely

The safest next step is to use contraindication information to prepare for a clinical conversation, not to self-screen yourself in or out of treatment. Bring an accurate health and medication history, ask how the proposed route will be supervised, and tell the clinician about changes in symptoms or health since your last visit.

For immediate safety concerns such as chest pain, severe shortness of breath, fainting, signs of stroke, or thoughts of harming yourself, seek urgent local help rather than waiting for a routine treatment discussion. For information about suicidal thoughts and available support, see suicidal ideation.